copes pharmacy limited Company Information
Company Number
04475604
Website
www.copes-pharmacy.co.ukRegistered Address
c/o croucher needham limited, market house, saffron walden, essex, CB10 1JZ
Industry
Dispensing chemist in specialised stores
Telephone
02087642910
Next Accounts Due
March 2025
Group Structure
View All
Directors
Ashok Soni22 Years
Shareholders
ashok soni 100%
copes pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of COPES PHARMACY LIMITED at £392.4k based on a Turnover of £1.5m and 0.27x industry multiple (adjusted for size and gross margin).
copes pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of COPES PHARMACY LIMITED at £0 based on an EBITDA of £-144.8k and a 3.56x industry multiple (adjusted for size and gross margin).
copes pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of COPES PHARMACY LIMITED at £0 based on Net Assets of £-295k and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Copes Pharmacy Limited Overview
Copes Pharmacy Limited is a live company located in saffron walden, CB10 1JZ with a Companies House number of 04475604. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 2002, it's largest shareholder is ashok soni with a 100% stake. Copes Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £1.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Copes Pharmacy Limited Health Check
Pomanda's financial health check has awarded Copes Pharmacy Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
![Health Check Image](/assets/images/big_heart.png)
![positive_score](/assets/images/scoreRate2.png)
1 Strong
![positive_score](/assets/images/scoreRate1.png)
5 Regular
![positive_score](/assets/images/scoreRate0.png)
6 Weak
![size](/assets/images/scoreRate0.png)
Size
annual sales of £1.5m, make it smaller than the average company (£12.1m)
- Copes Pharmacy Limited
£12.1m - Industry AVG
![growth](/assets/images/scoreRate2.png)
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (5.3%)
- Copes Pharmacy Limited
5.3% - Industry AVG
![production](/assets/images/scoreRate1.png)
Production
with a gross margin of 30.9%, this company has a comparable cost of product (30.9%)
- Copes Pharmacy Limited
30.9% - Industry AVG
![profitability](/assets/images/scoreRate0.png)
Profitability
an operating margin of -13.2% make it less profitable than the average company (2.2%)
- Copes Pharmacy Limited
2.2% - Industry AVG
![employees](/assets/images/scoreRate0.png)
Employees
with 20 employees, this is below the industry average (86)
20 - Copes Pharmacy Limited
86 - Industry AVG
![paystructure](/assets/images/scoreRate1.png)
Pay Structure
on an average salary of £22.7k, the company has an equivalent pay structure (£22.7k)
- Copes Pharmacy Limited
£22.7k - Industry AVG
![efficiency](/assets/images/scoreRate0.png)
Efficiency
resulting in sales per employee of £74k, this is less efficient (£138.2k)
- Copes Pharmacy Limited
£138.2k - Industry AVG
![debtordays](/assets/images/scoreRate1.png)
Debtor Days
it gets paid by customers after 26 days, this is near the average (31 days)
- Copes Pharmacy Limited
31 days - Industry AVG
![creditordays](/assets/images/scoreRate1.png)
Creditor Days
its suppliers are paid after 71 days, this is close to average (68 days)
- Copes Pharmacy Limited
68 days - Industry AVG
![stockdays](/assets/images/scoreRate1.png)
Stock Days
it holds stock equivalent to 27 days, this is in line with average (30 days)
- Copes Pharmacy Limited
30 days - Industry AVG
![cashbalance](/assets/images/scoreRate0.png)
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (16 weeks)
0 weeks - Copes Pharmacy Limited
16 weeks - Industry AVG
![debtlevel](/assets/images/scoreRate0.png)
Debt Level
it has a ratio of liabilities to total assets of 163.5%, this is a higher level of debt than the average (59.4%)
163.5% - Copes Pharmacy Limited
59.4% - Industry AVG
COPES PHARMACY LIMITED financials
![ms excel logo](/assets/images/ms_excel_logo.png)
Copes Pharmacy Limited's latest turnover from June 2023 is estimated at £1.5 million and the company has net assets of -£295 thousand. According to their latest financial statements, Copes Pharmacy Limited has 20 employees and maintains cash reserves of £3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 20 | 18 | 14 | 13 | 11 | 8 | 8 | 7 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 62,141 | 78,154 | 94,792 | 127,657 | 147,740 | 2 | 2 | 2 | 2 | 19,781 | 39,561 | 59,368 | 733 | 2,034 |
Intangible Assets | 168,600 | 202,878 | 237,156 | 271,434 | 305,712 | 19,680 | 22,960 | 26,240 | 29,520 | 32,800 | 36,080 | 39,360 | 42,640 | 45,920 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 45 | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 230,741 | 281,032 | 331,948 | 399,091 | 453,452 | 19,727 | 23,007 | 26,242 | 29,522 | 52,581 | 75,641 | 98,728 | 43,373 | 47,954 |
Stock & work in progress | 77,703 | 83,252 | 95,397 | 75,940 | 72,548 | 59,595 | 77,459 | 55,861 | 59,791 | 64,789 | 61,476 | 68,021 | 76,642 | 80,224 |
Trade Debtors | 109,182 | 99,307 | 328,593 | 142,437 | 131,290 | 67,234 | 102,025 | 59,622 | 113,727 | 69,418 | 79,335 | 84,160 | 129,536 | 121,775 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 43,756 | 80,533 | 79,771 | 95,702 | 94,442 | 61,460 | 21,155 | 25,957 | 0 | 18,239 | 61,999 | 75,385 | 93,851 | 46,779 |
Cash | 3,004 | 81,060 | 4,270 | 17,350 | 4,151 | 32,639 | 30,178 | 103,761 | 43,174 | 33,578 | 45,297 | 31,448 | 851 | 1,208 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 233,645 | 344,152 | 508,031 | 331,429 | 302,431 | 220,928 | 230,817 | 245,201 | 216,692 | 186,024 | 248,107 | 259,014 | 300,880 | 249,986 |
total assets | 464,386 | 625,184 | 839,979 | 730,520 | 755,883 | 240,655 | 253,824 | 271,443 | 246,214 | 238,605 | 323,748 | 357,742 | 344,253 | 297,940 |
Bank overdraft | 56,287 | 16,422 | 59,503 | 16,634 | 57,028 | 20,978 | 20,211 | 19,336 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 199,565 | 198,950 | 211,860 | 219,846 | 169,163 | 153,218 | 132,308 | 134,653 | 185,039 | 162,449 | 155,473 | 136,101 | 154,326 | 145,785 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 392,528 | 364,069 | 341,462 | 377,860 | 312,532 | 30,499 | 23,098 | 25,840 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 648,380 | 579,441 | 612,825 | 614,340 | 538,723 | 204,695 | 175,662 | 179,829 | 185,039 | 162,449 | 155,473 | 136,101 | 154,326 | 145,785 |
loans | 96,380 | 113,589 | 160,603 | 186,674 | 153,431 | 46,170 | 67,148 | 87,319 | 0 | 46,229 | 67,177 | 87,318 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 169,955 | 169,955 | 169,955 | 0 | 0 | 0 | 107,461 | 78,956 | 75,732 | 72,509 | 0 | 0 |
provisions | 14,633 | 18,578 | 17,234 | 23,429 | 27,114 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 111,013 | 132,167 | 347,792 | 380,058 | 350,500 | 46,170 | 67,148 | 87,319 | 107,461 | 125,185 | 142,909 | 159,827 | 0 | 0 |
total liabilities | 759,393 | 711,608 | 960,617 | 994,398 | 889,223 | 250,865 | 242,810 | 267,148 | 292,500 | 287,634 | 298,382 | 295,928 | 154,326 | 145,785 |
net assets | -295,007 | -86,424 | -120,638 | -263,878 | -133,340 | -10,210 | 11,014 | 4,295 | -46,286 | -49,029 | 25,366 | 61,814 | 189,927 | 152,155 |
total shareholders funds | -295,007 | -86,424 | -120,638 | -263,878 | -133,340 | -10,210 | 11,014 | 4,295 | -46,286 | -49,029 | 25,366 | 61,814 | 189,927 | 152,155 |
Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 16,013 | 16,638 | 17,062 | 20,083 | 13,180 | 0 | 0 | 0 | 19,779 | 19,780 | 19,807 | 20,484 | 1,301 | 1,301 |
Amortisation | 34,278 | 34,278 | 34,278 | 34,278 | 23,945 | 3,280 | 3,280 | 3,280 | 3,280 | 3,280 | 3,280 | 3,280 | 3,280 | 3,280 |
Tax | ||||||||||||||
Stock | -5,549 | -12,145 | 19,457 | 3,392 | 12,953 | -17,864 | 21,598 | -3,930 | -4,998 | 3,313 | -6,545 | -8,621 | -3,582 | 80,224 |
Debtors | -26,902 | -228,524 | 170,225 | 12,407 | 97,038 | 5,514 | 37,601 | -28,148 | 26,070 | -53,677 | -18,211 | -63,842 | 54,833 | 168,554 |
Creditors | 615 | -12,910 | -7,986 | 50,683 | 15,945 | 20,910 | -2,345 | -50,386 | 22,590 | 6,976 | 19,372 | -18,225 | 8,541 | 145,785 |
Accruals and Deferred Income | 28,459 | 22,607 | -36,398 | 65,328 | 282,033 | 7,401 | -2,742 | 25,840 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -3,945 | 1,344 | -6,195 | -3,685 | 27,114 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | -45 | 0 | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | -45 | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -17,209 | -47,014 | -26,071 | 33,243 | 107,261 | -20,978 | -20,171 | 87,319 | -46,229 | -20,948 | -20,141 | 87,318 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | -169,955 | 0 | 0 | 169,955 | 0 | 0 | -107,461 | 28,505 | 3,224 | 3,223 | 72,509 | 0 | 0 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -78,056 | 76,790 | -13,080 | 13,199 | -28,488 | 2,461 | -73,583 | 60,587 | 9,596 | -11,719 | 13,849 | 30,597 | -357 | 1,208 |
overdraft | 39,865 | -43,081 | 42,869 | -40,394 | 36,050 | 767 | 875 | 19,336 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -117,921 | 119,871 | -55,949 | 53,593 | -64,538 | 1,694 | -74,458 | 41,251 | 9,596 | -11,719 | 13,849 | 30,597 | -357 | 1,208 |
copes pharmacy limited Credit Report and Business Information
Copes Pharmacy Limited Competitor Analysis
![competitor_analysis_table_img](/assets/images/competitor_analysis_table.png)
Perform a competitor analysis for copes pharmacy limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
copes pharmacy limited Ownership
COPES PHARMACY LIMITED group structure
Copes Pharmacy Limited has 1 subsidiary company.
copes pharmacy limited directors
Copes Pharmacy Limited currently has 1 director, Mr Ashok Soni serving since Jul 2002.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Ashok Soni | 63 years | Jul 2002 | - | Director |
P&L
June 2023turnover
1.5m
+9%
operating profit
-195.1k
0%
gross margin
30.9%
-5.27%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
-295k
+2.41%
total assets
464.4k
-0.26%
cash
3k
-0.96%
net assets
Total assets minus all liabilities
copes pharmacy limited company details
company number
04475604
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
July 2002
age
22
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
c/o croucher needham limited, market house, saffron walden, essex, CB10 1JZ
last accounts submitted
June 2023
copes pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to copes pharmacy limited. Currently there are 2 open charges and 0 have been satisfied in the past.
![charges](/assets/images/company_charges.png)
copes pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|